Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 408
5
Diseases
8
Unique genes
0.189
Avg. similarity score
Hyperammonemia
Most-connected disease (4 links)
Disease
Searched: systemic lupus erythematosus, susceptibility to, 1
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
systemic lupus erythematosus, susceptibility to, 1
Hyperammonemia
Chromosome 22q11.2 deletion syndrome
interstitial lung disease due to ABCA3 deficiency
ornithine carbamoyltransferase deficiency
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Hyperammonemia | 4 | 4 | 8 |
| Chromosome 22q11.2 deletion syndrome | 2 | 2 | 1 |
| interstitial lung disease due to ABCA3 deficiency | 2 | 2 | 1 |
| ornithine carbamoyltransferase deficiency | 1 | 1 | 1 |
| systemic lupus erythematosus, susceptibility to, 1 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ABCA3 | 3 / 5 | Chromosome 22q11.2 deletion syndrome, Hyperammonemia, interstitial lung disease due to ABCA3 deficiency |
| OTC | 2 / 5 | Hyperammonemia, ornithine carbamoyltransferase deficiency |
| TLR5 | 2 / 5 | Hyperammonemia, systemic lupus erythematosus, susceptibility to, 1 |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Arginine biosynthesis | KEGG | 4 / 23 | 261× | 7.12e-10 | 8.63e-8 ✓ sig. |
| Urea cycle | Reactome | 3 / 10 | 450× | 2.32e-8 | 1.93e-6 ✓ sig. |
| Biosynthesis of amino acids | KEGG | 3 / 75 | 60.1× | 1.28e-5 | 4.35e-4 ✓ sig. |
| Nitrogen metabolism | KEGG | 2 / 17 | 177× | 5.25e-5 | 1.39e-3 ✓ sig. |
| Alanine, aspartate and glutamate metabolism | KEGG | 2 / 37 | 81.1× | 2.56e-4 | 4.85e-3 ✓ sig. |
| Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3) | Reactome | 1 / 1 | 1,501× | 6.66e-4 | 1.03e-2 ✓ sig. |
| Defective ABCA3 causes pulmonary surfactant metabolism dysfunction 3 (SMDP3) | Reactome | 1 / 1 | 1,501× | 6.66e-4 | 1.03e-2 ✓ sig. |
| Toll Like Receptor 5 (TLR5) Cascade | Reactome | 1 / 1 | 1,501× | 6.66e-4 | 1.03e-2 ✓ sig. |
| MyD88 deficiency (TLR5) | Reactome | 1 / 2 | 751× | 1.33e-3 | 1.75e-2 ✓ sig. |
| Metabolic pathways | KEGG | 5 / 1,563 | 4.8× | 1.48e-3 | 1.90e-2 ✓ sig. |
| Carbon metabolism | KEGG | 2 / 115 | 26.1× | 2.45e-3 | 2.74e-2 ✓ sig. |
| IRAK4 deficiency (TLR5) | Reactome | 1 / 4 | 375× | 2.66e-3 | 2.91e-2 ✓ sig. |
| MyD88 cascade initiated on plasma membrane | Reactome | 1 / 9 | 167× | 5.98e-3 | 5.11e-2 |
| Glutamate and glutamine metabolism | Reactome | 1 / 14 | 107× | 9.29e-3 | 6.78e-2 |
| ABC transporters in lipid homeostasis | Reactome | 1 / 18 | 83.4× | 1.19e-2 | 7.90e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| urea cycle | GO:0000050 | 3 / 12 | 584× | 1.13e-8 | 1.89e-6 ✓ sig. |
| monoatomic anion homeostasis | GO:0055081 | 2 / 2 | 2,336× | 1.60e-7 | 1.84e-5 ✓ sig. |
| L-arginine biosynthetic process | GO:0006526 | 2 / 4 | 1,168× | 9.62e-7 | 8.18e-5 ✓ sig. |
| citrulline biosynthetic process | GO:0019240 | 2 / 4 | 1,168× | 9.62e-7 | 8.18e-5 ✓ sig. |
| midgut development | GO:0007494 | 2 / 8 | 584× | 4.48e-6 | 2.83e-4 ✓ sig. |
| glutamine metabolic process | GO:0006541 | 2 / 15 | 311× | 1.68e-5 | 8.09e-4 ✓ sig. |
| response to zinc ion | GO:0010043 | 2 / 27 | 173× | 5.60e-5 | 2.02e-3 ✓ sig. |
| amino acid metabolic process | GO:0006520 | 2 / 37 | 126× | 1.06e-4 | 3.27e-3 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 3 / 248 | 28.3× | 1.23e-4 | 3.64e-3 ✓ sig. |
| response to glucocorticoid | GO:0051384 | 2 / 53 | 88.1× | 2.19e-4 | 5.54e-3 ✓ sig. |
| carbamoyl phosphate biosynthetic process | GO:0070409 | 1 / 1 | 2,336× | 4.28e-4 | 8.87e-3 ✓ sig. |
| L-ornithine catabolic process | GO:0006593 | 1 / 1 | 2,336× | 4.28e-4 | 8.87e-3 ✓ sig. |
| positive regulation of protein homooligomerization | GO:0032464 | 1 / 1 | 2,336× | 4.28e-4 | 8.87e-3 ✓ sig. |
| liver development | GO:0001889 | 2 / 87 | 53.7× | 5.89e-4 | 1.10e-2 ✓ sig. |
| L-arginine biosynthetic process via ornithine | GO:0042450 | 1 / 2 | 1,168× | 8.56e-4 | 1.41e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Chromosome 22q11.2 deletion syndrome | interstitial lung disease due to ABCA3 deficiency | 0.500 | 1 | 6.49e-5 | 2.33e-4 ✓ sig. |
| Chromosome 22q11.2 deletion syndrome | Hyperammonemia | 0.111 | 1 | 5.20e-4 | 1.06e-3 ✓ sig. |
| Hyperammonemia | systemic lupus erythematosus, susceptibility to, 1 | 0.111 | 1 | 5.20e-4 | 1.06e-3 ✓ sig. |
| Hyperammonemia | ornithine carbamoyltransferase deficiency | 0.111 | 1 | 5.20e-4 | 1.06e-3 ✓ sig. |
| Hyperammonemia | interstitial lung disease due to ABCA3 deficiency | 0.111 | 1 | 5.20e-4 | 1.06e-3 ✓ sig. |